222 related articles for article (PubMed ID: 17448279)
1. [Effect of imatinib mesylate on bleomycin-induced pulmonary fibrosis in mice].
Li L; Li YQ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):229-32. PubMed ID: 17448279
[TBL] [Abstract][Full Text] [Related]
2. Effect of nilotinib on bleomycin-induced acute lung injury and pulmonary fibrosis in mice.
Rhee CK; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim YK; Kim KH; Kim TJ; Kim JW
Respiration; 2011; 82(3):273-87. PubMed ID: 21659722
[TBL] [Abstract][Full Text] [Related]
3. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice.
Aono Y; Nishioka Y; Inayama M; Ugai M; Kishi J; Uehara H; Izumi K; Sone S
Am J Respir Crit Care Med; 2005 Jun; 171(11):1279-85. PubMed ID: 15735062
[TBL] [Abstract][Full Text] [Related]
4. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.
Kubo T; Piperdi S; Rosenblum J; Antonescu CR; Chen W; Kim HS; Huvos AG; Sowers R; Meyers PA; Healey JH; Gorlick R
Cancer; 2008 May; 112(10):2119-29. PubMed ID: 18338812
[TBL] [Abstract][Full Text] [Related]
6. [Effect of gualou xiebai (GLXB) decoction on platelet-derived growth factor BB (PDGF-BB) expression in lungs from bleomycin A5 induced pulmonary fibrosis in rats].
Li RQ; Xiao H; Zhang R; Li W; Song JP
Zhongguo Zhong Yao Za Zhi; 2008 Nov; 33(22):2666-70. PubMed ID: 19216168
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide Combined with Bone Marrow Mesenchymal Stromal Cells Protects against Bleomycin-induced Lung Fibrosis in Mice.
Xu J; Li L; Xiong J; Zheng Y; Ye Q; Li Y
Ann Clin Lab Sci; 2015; 45(3):292-300. PubMed ID: 26116593
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model.
Chaudhary NI; Schnapp A; Park JE
Am J Respir Crit Care Med; 2006 Apr; 173(7):769-76. PubMed ID: 16415276
[TBL] [Abstract][Full Text] [Related]
9. Imatinib mesylate has the potential to exert its efficacy by down-regulating the plasma concentration of platelet-derived growth factor in patients with pulmonary arterial hypertension.
Hatano M; Yao A; Shiga T; Kinugawa K; Hirata Y; Nagai R
Int Heart J; 2010 Jul; 51(4):272-6. PubMed ID: 20716845
[TBL] [Abstract][Full Text] [Related]
10. [Effects of 1, 25 (OH)2D3 on bleomycin-induced pulmonary fibrosis in mice].
Zhang ZM; Gu P; Yi XH; Fang X; Zeng Y; Zhang SX; Zhu XY; Zhang YD; Gu J; Qiu WZ; Zhang L
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):814-20. PubMed ID: 24507391
[TBL] [Abstract][Full Text] [Related]
11. [Effects of cordyceps sinensi on bleomycin-induced pulmonary fibrosis in mice].
Wang SJ; Bai W; Wang CL; Dai Z
Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(24):2623-7. PubMed ID: 18338602
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib.
Chilakapati SR; Serasanambati M; Vissavajjhala P; Kanala JR; Chilakapati DR
Exp Lung Res; 2015 May; 41(4):173-88. PubMed ID: 25844688
[TBL] [Abstract][Full Text] [Related]
13. Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.
van Steensel L; Paridaens D; Schrijver B; Dingjan GM; van Daele PL; van Hagen PM; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3091-8. PubMed ID: 19234339
[TBL] [Abstract][Full Text] [Related]
14. Role of platelet-derived growth factor/platelet-derived growth factor receptor axis in the trafficking of circulating fibrocytes in pulmonary fibrosis.
Aono Y; Kishi M; Yokota Y; Azuma M; Kinoshita K; Takezaki A; Sato S; Kawano H; Kishi J; Goto H; Uehara H; Izumi K; Nishioka Y
Am J Respir Cell Mol Biol; 2014 Dec; 51(6):793-801. PubMed ID: 24885373
[TBL] [Abstract][Full Text] [Related]
15. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
[TBL] [Abstract][Full Text] [Related]
16. [Influence of Feixian Formula on serum transforming growth factor-beta1 and platelet-derived growth factor in rats with bleomycin-induced pulmonary fibrosis].
Zhang W; Jiang LD; Zhang XM; Wu JJ; Deng Y; Lu XF
Zhong Xi Yi Jie He Xue Bao; 2008 Jun; 6(6):595-9. PubMed ID: 18559237
[TBL] [Abstract][Full Text] [Related]
17. Imatinib mesylate inhibits fibrogenesis in asbestos-induced interstitial pneumonia.
Vuorinen K; Gao F; Oury TD; Kinnula VL; Myllärniemi M
Exp Lung Res; 2007 Sep; 33(7):357-73. PubMed ID: 17849262
[TBL] [Abstract][Full Text] [Related]
18. Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases.
Vittal R; Zhang H; Han MK; Moore BB; Horowitz JC; Thannickal VJ
J Pharmacol Exp Ther; 2007 Apr; 321(1):35-44. PubMed ID: 17218487
[TBL] [Abstract][Full Text] [Related]
19. Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis.
Akhmetshina A; Venalis P; Dees C; Busch N; Zwerina J; Schett G; Distler O; Distler JH
Arthritis Rheum; 2009 Jan; 60(1):219-24. PubMed ID: 19116940
[TBL] [Abstract][Full Text] [Related]
20. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis.
Daniels CE; Wilkes MC; Edens M; Kottom TJ; Murphy SJ; Limper AH; Leof EB
J Clin Invest; 2004 Nov; 114(9):1308-16. PubMed ID: 15520863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]